Please wait while the formulary information is being retrieved.
LOTEMAX SM (loteprednol etabonate)
- Post-op ocular inflammation
- Postoperative ocular pain
0.38 % eye gel drops
- Instill 1 drop into affected eye(s) by ophthalmic route 3 times per day beginning the day after surgery and continuing for 2 weeks post-op
Post-op ocular inflammation
- Instill 1 drop into left eye by ophthalmic route 3 times per day beginning the day after surgery and continuing for 2 weeks post-op
- Instill 1 drop into right eye by ophthalmic route 3 times per day beginning the day after surgery and continuing for 2 weeks post-op
- Instill 1 drop into both eyes by ophthalmic route 3 times per day beginning the day after surgery and continuing for 2 weeks post-op
- Instill 1 drop into affected eye(s) by ophthalmic route 3 times per day beginning the day after surgery and continuing for 2 weeks post-op
Postoperative ocular pain
- Instill 1 drop into left eye by ophthalmic route 3 times per day beginning the day after surgery and continuing for 2 weeks post-op
- Instill 1 drop into right eye by ophthalmic route 3 times per day beginning the day after surgery and continuing for 2 weeks post-op
- Instill 1 drop into both eyes by ophthalmic route 3 times per day beginning the day after surgery and continuing for 2 weeks post-op
- Instill 1 drop into affected eye(s) by ophthalmic route 3 times per day beginning the day after surgery and continuing for 2 weeks post-op
- None
Contraindicated
- None
Severe
Moderate
- None
- Fungal infection of eye
- Herpes simplex dendritic keratitis
- Tuberculosis of the eye
- Vaccinia virus keratitis
Contraindicated
- Glaucoma
- Ocular hypertension
Severe
Moderate
- None
LOTEMAX SM (loteprednol etabonate)
- Post-op ocular inflammation
- Postoperative ocular pain
- Chemosis
- Anterior chamber inflammation
- Blurred vision
- Dry eye
- Eye tearing
- Headache disorder
- Ocular itching
- Ocular pain
- Ocular redness
- Pharyngitis
- Photophobia
- Rhinitis
- Visual changes
More Frequent
Severe
Less Severe
- Disorder of cornea
- Keratoconjunctivitis
- Uveitis
- Conjunctivitis
- Eyelid erythema
- Ocular discharge
- Ocular hypertension
- Ocular irritation
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Bacterial eye infection
- Cataracts
- Fungal infection of eye
- Glaucoma
- Globe perforation
- Impaired wound healing
- Ocular infection
- Viral ocular infection
Less Severe
- Foreign body sensation of eye
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Loteprednol
- Severity Level:
2
- Additional Notes: Insufficient human data available.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Loteprednol
Insuff data; systemic absorption unknown; potential for adverse effect in inf
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insuff data; systemic absorption unknown; potential for adverse effect in inf |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Post-op ocular inflammation | |
| H57.8 | Other specified disorders of eye and adnexa |
| Postoperative ocular pain | |
| H57.1 | Ocular pain |
| H57.10 | Ocular pain, unspecified eye |
| H57.11 | Ocular pain, right eye |
| H57.12 | Ocular pain, left eye |
| H57.13 | Ocular pain, bilateral |
| 0-9 | A-Z |
|---|---|
| H57.1 | Ocular pain |
| H57.10 | Ocular pain, unspecified eye |
| H57.11 | Ocular pain, right eye |
| H57.12 | Ocular pain, left eye |
| H57.13 | Ocular pain, bilateral |
| H57.8 | Other specified disorders of eye and adnexa |
Formulary Reference Tool